@prefix this: . @prefix sub: . @prefix np: . @prefix rdf: . @prefix xsd: . @prefix rdfs: . @prefix ns2: . @prefix ns1: . @prefix prov: . @prefix ns3: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubInfo; a np:Nanopublication . } sub:assertion { sub:assertion prov:wasGeneratedBy "S&T TWOC project version 1" . sub:version prov:value "1"^^xsd:integer . rdf:object ns1:C1292423 "72 hours"; ns1:C2986530 "Intervention Group" . rdf:predicate ns2:TRIPLE_UID:mapu4r1z-TRIPLE-ABSTRACT-13 "continue" . rdf:subject ns1:C0001554 "administration"; ns1:C0011777 "dexamethasone"; ns1:C1533734 "administration"; ns1:C2348003 "administration" . rdfs:Triple-UID ns3:TRIPLE_UID:mapu4r1z-TRIPLE-ABSTRACT-13 "mapu4r1z-TRIPLE-ABSTRACT-13" . rdfs:sentence rdfs:label "In Intervention Group 2, the administration of dexamethasone will be started within the first 24 hours' time of admission and will be continued for 48-72 hours and then the level of SpO2 will be checked." . rdfs:triple rdfs:label "the administration of dexamethasone continued In Intervention Group 2, will, for 48 - 72 hours" . } sub:provenance { sub:assertion prov:generatedAtTime "2021-07-25T21:46:32.502934"^^xsd:dateTime . } sub:pubInfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB"; npx:hasSignature "fWo4HJ87Z9uniFiZgZ1VMFo6Og4xLxJbo3UXVLeCXuorkK2TU2K3NH4EJSIjIyIeqa40OeQUi2MOeenJNxY1GekZCt7A4uNKqvj7ym/73bYaoy63CrvgDFYVPlhrUTJ7fMNwu/Wme8vPKsBsxnbpJriWRxVLC4M3WrpvmQGVCec="; npx:hasSignatureTarget this: . this: prov:generatedAtTime "2021-07-25T21:46:32.502934"^^xsd:dateTime; prov:wasAttributedTo . }